Tech Company Financing Transactions
Samumed Funding Round
On 8/7/2018, Samumed raised $438 million in investment from private investors.
Transaction Overview
Company Name
Announced On
8/7/2018
Transaction Type
Venture Equity
Amount
$438,000,000
Round
Undisclosed
Investors
Proceeds Purpose
We are now in a fortunate position to both move our later stage programs to commercialization, as well as expand on our earlier stage science and clinical portfolio.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
9381 Judicial Dr.
San Diego, CA 92121
USA
San Diego, CA 92121
USA
Phone
Website
Email Address
Overview
Samumed is a leader in medical research and development for tissue-level regeneration. With our platform's origins in small molecule-based Wnt pathway modulation (See Technology), we develop therapeutics to address a range of degenerative diseases, regenerative medicine and oncology.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Osman Kibar
Chief Financial Officer
Cevdet Samikoglu
Chief Information Officer
Blake Mobley
Chief Medical Officer
Yusuf Yazici
Chief Operating Officer
Philippe Marchand
Vice President
Neil Bair
Vice President
Sunil KC
Vice President
Todd Smith
Vice President
Christopher Swearingen
VP - Bus. Development
Anita DiFrancesco
VP - Bus. Development
Erich Horsley
VP - General Counsel
Arman Oruc
VP - Marketing
Gary Choy
VP - Regulatory Affairs
Jeymi Tambiah
Browse more venture capital transactions:
Prev: 8/7/2018: AttackIQ venture capital transaction
Next: 8/7/2018: Portion venture capital transaction
Share this article
About Database of VC Transactions
We record every notable VC transaction. All VC database entries on this site come from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs